Literature DB >> 22197965

The phylogeny of yellow fever virus 17D vaccines.

Nina K Stock1, Nicola Boschetti, Christian Herzog, Marc S Appelhans, Matthias Niedrig.   

Abstract

In recent years the safety of the yellow fever live vaccine 17D came under scrutiny. The focus was on serious adverse events after vaccinations that resemble a wild type infection with yellow fever and whose reasons are still not known. Also the exact mechanism of attenuation of the vaccine remains unknown to this day. In this context, the standards of safety and surveillance in vaccine production and administration have been discussed. Therein embodied was the demand for improved documentation of the derivation of the seed virus used for yellow fever vaccine production. So far, there was just a historical genealogy available that is based on source area and passage level. However, there is a need for a documentation based on molecular information to get better insights into the mechanisms of pathology. In this work we sequenced the whole genome of different passages of the YFV-17D strain used by Crucell Switzerland AG for vaccine production. Using all other publically available 17D full genome sequences we compared the sequence variance of all vaccine strains and oppose a phylogenetic tree based on full genome sequences to the historical genealogy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197965     DOI: 10.1016/j.vaccine.2011.12.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Experimental therapies for yellow fever.

Authors:  Justin G Julander
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

2.  A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Authors:  Jue Hou; Shuhui Wang; Manxue Jia; Dan Li; Ying Liu; Zhengpeng Li; Hong Zhu; Huifang Xu; Meiping Sun; Li Lu; Zhinan Zhou; Hong Peng; Qichen Zhang; Shihong Fu; Guodong Liang; Lena Yao; Xuesong Yu; Lindsay N Carpp; Yunda Huang; Julie McElrath; Steve Self; Yiming Shao
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

Review 3.  Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review.

Authors:  Roger E Thomas; Diane L Lorenzetti; Wendy Spragins
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 4.  Current status and future prospects of yellow fever vaccines.

Authors:  Andrew S Beck; Alan D T Barrett
Journal:  Expert Rev Vaccines       Date:  2015-09-14       Impact factor: 5.217

5.  Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa.

Authors:  Nina K Stock; Hewád Laraway; Ousmane Faye; Mawlouth Diallo; Matthias Niedrig; Amadou A Sall
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

6.  Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections.

Authors:  Holly R Hughes; Brandy J Russell; Eric C Mossel; John Kayiwa; Julius Lutwama; Amy J Lambert
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

Review 7.  Flavivirus-mosquito interactions.

Authors:  Yan-Jang S Huang; Stephen Higgs; Kate McElroy Horne; Dana L Vanlandingham
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

8.  Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains.

Authors:  Andrew S Beck; Thomas G Wood; Steven G Widen; Jill K Thompson; Alan D T Barrett
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

9.  Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali.

Authors:  Panchali Roy Chowdhury; Christian Meier; Hewad Laraway; Yuxiao Tang; Abraham Hodgson; Samba O Sow; Godwin C Enwere; Brian D Plikaytis; Prasad S Kulkarni; Marie-Pierre Preziosi; Matthias Niedrig
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

10.  17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Authors:  Reinaldo M Martins; Maria de Lourdes S Maia; Roberto Henrique G Farias; Luiz Antonio B Camacho; Marcos S Freire; Ricardo Galler; Anna Maya Yoshida Yamamura; Luiz Fernando C Almeida; Sheila Maria B Lima; Rita Maria R Nogueira; Gloria Regina S Sá; Darcy A Hokama; Ricardo de Carvalho; Ricardo Aguiar V Freire; Edson Pereira Filho; Maria da Luz Fernandes Leal; Akira Homma
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.